Are young infants treated with erythromycin at risk for developing hypertrophic pyloric stenosis?
Maheshwai
Nitin
N
nitin023@rediffmail.com
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D004917:Erythromycin / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D046248:Pyloric Stenosis, Hypertrophic / Q000139:chemically induced*; D012307:Risk Factors; D014917:Whooping Cough / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D004917:Erythromycin